Erratum in: Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema". . Invest Ophthalmol Vis Sci 2025;66:64.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Erratum in: Comments on "Real-World Outcomes After Switch From Aflibercept to Faricimab in Eyes With Diabetic Macular Edema". Invest Ophthalmol Vis Sci 2025;66:64.
PMID: 41020557